No Record Found
Sector
PharmaceuticalsOpen
₹689.5Prev. Close
₹689.9Turnover(Lac.)
₹1,184.89Day's High
₹694.45Day's Low
₹68152 Week's High
₹751.252 Week's Low
₹435.25Book Value
₹154.31Face Value
₹10Mkt Cap (₹ Cr.)
3,149.37P/E
0EPS
1.32Divi. Yield
0
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 46.05 | 30.51 | 9.82 | 8.74 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 661.92 | 137.61 | 29.11 | 24.95 |
Net Worth | 707.97 | 168.12 | 38.93 | 33.69 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Gross Sales | 377.98 | 214.52 | 35.34 | 14.17 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 377.98 | 214.52 | 35.34 | 14.17 |
Other Operating Income | 20.27 | 0 | 0 | 0 |
Other Income | 19.26 | 2.82 | 3.68 | 0.46 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,616.6 | 77.85 | 3,87,792.51 | 753.53 | 0.99 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,026.5 | 68.48 | 1,59,985.97 | 557 | 0.5 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,574.6 | 24.61 | 1,27,124.34 | 1,303.13 | 1.02 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,566.2 | 60.71 | 1,20,694.38 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,316.7 | 15.94 | 1,09,867.7 | 2,961.2 | 0.61 | 7,788.7 | 345.75 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
SWAPNIL JATINBHAI SHAH
Chairman (Non-Executive)
Sanjay Majmudar
Non Executive Director
Hemanshu Nitinchandra Pandya
Independent Director
Jitendra Babulal Sanghvi
Whole Time Director & Chief Operating Officer
Chetan Bipinchandra Shah
Whole Time Director & Chief Financial Officer
Deval Rajnikant Shah
Non Executive Director
Ashokkumar Vijaysinh Barot
Non Executive Director
ARPIT DEEPAKKUMAR SHAH
Independent Director
Naresh Bansilal Shah
Independent Director
Manjula Devi Shroff
Independent Director
Kalpit Rajesh Gandhi
Independent Director
Udayan Choksi
Company Sec. & Compli. Officer
Nidhi Dilipbhai Kapadia
#.1101-1103 11th Flr South Twr,
Ambali Bopal Road,
Gujarat - 380054
Tel: +91-79-2999 9857
Website: http://www.senorespharma.com
Email: cs@senorespharma.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Senores Pharmaceuticals Limited was originally incorporated as Senores Pharmaceuticals Private Limited through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Compan...
Read More
Reports by Senores Pharmaceuticals Ltd
What is the Senores Pharmaceuticals Ltd share price today?
What is the Market Cap of Senores Pharmaceuticals Ltd?
What is the PE and PB ratio of Senores Pharmaceuticals Ltd?
What is the 52 Week High and Low of Senores Pharmaceuticals Ltd?
What is the CAGR of Senores Pharmaceuticals Ltd?
What is the shareholding pattern of Senores Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
